Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Zydus Life jumps on USFDA nod for BP lowering drug

Zydus Lifesciences advanced 3.89% to Rs 1,137.20 after the drug maker received tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil tablets.

By: business-standard.com

Jul 04 2024
157
11015 Views

Zydus Life jumps on USFDA nod for BP lowering drug

Zydus Life jumps on USFDA nod for BP lowering drug

Related

PEL board OKs ad hoc appointments post Rupen Patel's passing

Emcure Pharmaceuticals IPO ends with stellar subscription

Tricom Fruit Products reports standalone net loss of Rs 0.05 crore in the June 2024 quarter

Info Edge Q1 FY25 billings climb 11% YoY

Bansal Wire Industries IPO ends with strong subscription

IndusInd Bank advances climb 16% YoY in Q1 FY25

Adani Wilmar reports 13% volume growth in Q1 FY25

Share India Securities allots 16.92 lakh equity shares on conversion of warrants

Marico's domestic biz sees modest volume growth in Q1

Tata Motors JLR wholesale rises 5% YoY in Q1

Dabur India expects mid to high digit revenue growth in Q1

Integra Essentia announces merger with G G Engineering

PEL board OKs ad hoc appointments post Rupen Patel's passing